The Patient-Centered Outcomes Research Institute (PCORI) announced funding awards totaling $208 million to support 17 new comparative clinical effectiveness research (CER) studies. In addition, they awarded $2 million for a project intended to accelerate the adoption of strategies shown in a PCORI-funded study to improve mental health care for people who are receiving dialysis.
Congratulations to the following from the Department of Medicine who received awards:
Dr. Julie Gralow, professor emeritus (Medical Oncology) has received $11 million for a study that focuses on older patients (age 65 years and older) with hormone receptor positive metastatic breast cancer. The primary purpose of this study is to compare dosing strategies for two CDK4/6 inhibitors (palbociclib and ribociclib).
